|
Mechanism30S subunit inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1995 |
100 Clinical Results associated with Sunflower Pharmaceutical Group Jizhou Co. Ltd.
0 Patents (Medical) associated with Sunflower Pharmaceutical Group Jizhou Co. Ltd.
100 Deals associated with Sunflower Pharmaceutical Group Jizhou Co. Ltd.
100 Translational Medicine associated with Sunflower Pharmaceutical Group Jizhou Co. Ltd.